Sulfaproxiline

CAS No. 116-42-7

Sulfaproxiline ( Sulfaproxylin; Sulfaproxyline; Sulphaproxyline )

Catalog No. M26469 CAS No. 116-42-7

Sulfaproxiline is a synthetic antibacterial drug of sulfonamide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 101 Get Quote
10MG 143 Get Quote
25MG 258 Get Quote
50MG 375 Get Quote
100MG 557 Get Quote
500MG 1197 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Sulfaproxiline
  • Note
    Research use only, not for human use.
  • Brief Description
    Sulfaproxiline is a synthetic antibacterial drug of sulfonamide.
  • Description
    Sulfaproxiline is a synthetic antibacterial drug of sulfonamide.
  • Synonyms
    Sulfaproxylin; Sulfaproxyline; Sulphaproxyline
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    PDE4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    116-42-7
  • Formula Weight
    334.4
  • Molecular Formula
    C16H18N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)Oc1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bruno O, Brullo C, Arduino N, Schenone S, Ranise A, Bondavalli F, Ottonello L, Dapino P, Dallegri F. Synthesis and biological evaluation of neutrophilic inflammation inhibitors. Farmaco. 2004 Mar;59(3):223-35.
molnova catalog
related products
  • PBP 10

    Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.

  • Praeruptorin A(b)

    Praeruptorin A has the potential to inhibit migration/fusion of preosteoclasts in vitro and bone erosion in vivo by targeting calmodulin and inhibiting the Ca(2+)/calmodulin-CaMKIV-CREB-NFATc1 and/or Ca(2+)/calmodulin-calcineurin-NFATc1 signaling axis.

  • Sultamicillin

    Sultamicillin is an orally active double prodrug of Ampicillin/Sulbactan. Sulbactam is a semisynthetic β-Lactamase inhibitor.